JPRN-UMIN000047758已完成未知
Multicenter study for biomarker on therapeutic effect and safety of Atezolizumab + Bevacizumab in patients with unresectable hepatocellular carcinoma - Study on biomarkers in treatment with Atezolizumab + Bevacizumab for hepatocellular carcinoma
agoya University Graduate School of Medicine0 个研究点目标入组 99 人开始时间: 2022年5月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 99
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who wish to be excluded from the study. Patients who are pregnant, or lactating, may become pregnant, intend to become pregnant, or who wish to have a baby. Patients with the following serious complications: 1. Cardiovascular abnormalities such as heart failure, angina pectoris, or arrhythmia are difficult to control even after treatment. 2. Myocardial infarction within 6 months of onset 3. Renal failure 4. Active infectious disease except for viral hepatitis 5. Active gastrointestinal bleeding 6. Other active cancer requiring treatment 7. Hepatic encephalopathy or severe mental disorder 8. Severe drug allergy 9. Serious autoimmune disease. Other conditions that the physician deems inappropriate for the safe conduct of this study.
研究者
相似试验
招募中
不适用
A multicenter study for validation of biomarkers and observational study for immune regulatory mechanisms in Juvenile Dermatomyositisrheumatic muscle disease1000381610028302juvenile dermatomyositisNL-OMON50706niversitair Medisch Centrum Utrecht365
已完成
不适用
A Multicenter Study on Biomarker Development Utilizing AI Multiomics for Patients with Advanced Solid Malignant TumorsAdvanced Solid MalignanciesJPRN-UMIN000043899ational Cancer Center Hospital East2,768
招募中
不适用
A single arm multicenter biomarker study determining the response to taxane-based chemotherapy in metastatic breast cancer patients with ESR1 mutations in cellfree DNAbreast cancer, metastasis, ESR1 mutations, chemotherapyNL-OMON25511Erasmus MC Cancer Institute, department of Medical Oncology185
招募中
不适用
A single arm multicenter biomarker study determining the response to taxane-based chemotherapy in metastatic breast cancer (MBC) patients with ESR1 mutations in cell-free DNA: TAX-ESR1 study.Metastasis of breast cancer10006291NL-OMON46354Erasmus MC, Universitair Medisch Centrum Rotterdam175
已完成
不适用
Multicenter research study on therapeutic efficacy and prognosis of inflammatory bowel diseaseInflammatory bowel diseaseJPRN-UMIN000017856Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University1,850